JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gupta, R.
Right arrow Articles by Das, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gupta, R.
Right arrow Articles by Das, S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2006, p. 709-715, Vol. 44, No. 3
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.3.709-715.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Analysis of Mutations within the 5' Untranslated Region, Interferon Sensitivity Region, and PePHD Region as a Function of Response to Interferon Therapy in Hepatitis C Virus-Infected Patients in India

Romi Gupta,1,{dagger} Murugan Subramani,1,{dagger} Mohammed N. Khaja,2 Chandra Madhavi,2 Swagata Roy,1 Chittoor M. Habibullah,2 and Saumitra Das1*

Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore-560012, India,1 Center for Liver Research and Diagnostics, Deccan College of Medical Sciences and Allied Hospitals, Hyderabad 500056, India2

Received 31 July 2005/ Returned for modification 21 November 2005/ Accepted 6 December 2005

Mutations in several subgenomic regions have been implicated in influencing response to interferon therapy; however, a comprehensive picture of Indian patients was lacking. Based on the viral load and clinical factors, 10 out of 15 patients were found to be complete responders, whereas 5 patients were nonresponders. The pretreatment viral RNA load of the patients was found to be between 5.20 and 6.13 log10 IU/ml, which eventually fell to 2.77 log10 IU/ml after 24 weeks of treatment, whereas in the case of nonresponders, the average was 5.38 log10 IU/ml. In order to study the influence of the hepatitis C virus genotype on the response to interferon therapy, the 5' untranslated region sequences of the samples were analyzed, which showed that genotype 3 patients responded better than genotype 1 patients. Additionally, the mutations in the interferon sensitivity-determining region (ISDR) of the NS5A protein and the double-stranded RNA-activated protein kinase-eukaryotic initiation factor 2 alpha phosphorylation homology domain (PePHD) of the E2 envelope protein, before and after treatment, were compared with nonresponder prototype J. Although, no clear correlation was found in the case of the mutated ISDR, some significant changes in residues were observed in the PePHD region, which could be helpful in understanding the molecular basis of resistance to therapy. Interestingly, analysis of the quasispecies variations showed a change in genotype in one sample during treatment, which might have contributed to the resistance. The results suggest that the mutations in different regions of the viral genome might have a concerted effect on the response to interferon therapy.


* Corresponding author. Mailing address: Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore-560012, India. Phone: 91 80 22932886. Fax: 91 80 23602697. E-mail: sdas{at}mcbl.iisc.ernet.in.

{dagger} The first two authors contributed equally to this work.


Journal of Clinical Microbiology, March 2006, p. 709-715, Vol. 44, No. 3
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.3.709-715.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.